Cryonics in Ireland
Topic 4.2

The trust barrier

You are asked to trust an organization with something that cannot be verified until long after you are gone. Skepticism is the right starting point. This topic exists to show you what evidence you can inspect today: how a provider states its uncertainty, whether its procedures and case reports are public, what its facility and storage arrangements look like, and how patient care is kept separate from the commercial company. It also explains what a European provider changes for a European member and what it does not. The goal is to replace a vague feeling of scam or safety with concrete checks you can run yourself.

Is this a scam that exploits desperate people?Tomorrow.bio is not selling guaranteed revival. Judge the service by its explicit uncertainty, documented procedures, operating facility, public reports and separated patient-care structure.What a European provider changes, and what it does notFor Europeans, a regional provider reduces avoidable distance by bringing response, field cryoprotection and cross-border coordination closer to the patient, with long-term storage in Switzerland.Inside EBF's long-term storage facilityEBF is Tomorrow.bio's Swiss sister organization and the long-term storage facility for its members. Operational since 2022, it combines purpose-built infrastructure, measurable quality, cryogenic engineering and independent patient governance.Why members believe in Tomorrow.bioMembers value Tomorrow.bio because its support is knowledgeable, responsive and human. Strong public reviews also reflect trust in the company’s transparency, scientific work and mission.